Literature DB >> 35690034

The chosen and the unchosen: How eligibility for liver transplant influences the lived experiences of patients with advanced liver disease.

Caroline Gray1, Jennifer Arney2, Jack A Clark3, Anne M Walling4, Fasiha Kanwal5, Aanand D Naik6.   

Abstract

Advanced liver disease is often uncurable and fatal. Liver transplant is the only curative option for patients with advanced, irreversible liver disease, but the need for new livers far exceeds the supply. Patients with the greatest need as well as the greatest likelihood of benefit, based on a complex array of biomedical and psychosocial considerations, are prioritized for transplant. The opportunity to receive a life-saving surgery no doubt has enormous consequences for patients and their healthcare providers, as does the absence of that opportunity. But these consequences are poorly characterized, especially for patients deemed poor candidates for liver transplant. Through in-depth interviews with patients living with advanced liver disease and the providers who care for them, we explore how eligibility status affects illness experiences, including patients' interactions with clinicians, knowledge about their disease, expectations for the future, and efforts to come to terms with a life-limiting illness. We describe how the clinical and social requirements needed to secure eligibility for liver transplant lend themselves to a clinical and cultural logic that delineates "worthy" and "unworthy" patients. We describe how providers and candidates discuss the possibility of moral redemption for such patients through transplant surgeries, a discourse notably absent among patients not eligible for transplant.
Copyright © 2022 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic disease; Cirrhosis; Qualitative; Transplant; United States; Veterans

Mesh:

Year:  2022        PMID: 35690034      PMCID: PMC9319489          DOI: 10.1016/j.socscimed.2022.115113

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   5.379


  39 in total

Review 1.  A Review of the Current State of Liver Transplantation Disparities.

Authors:  Nabeel A Wahid; Russell Rosenblatt; Robert S Brown
Journal:  Liver Transpl       Date:  2021-02       Impact factor: 5.799

2.  Racial disparities in patient selection for liver transplantation: An ongoing challenge.

Authors:  Michelle T Jesse; Marwan Abouljoud; Eric D Goldstein; Nicholas Rebhan; Chuan-Xing Ho; Taylor Macaulay; Mubera Bebanic; Lina Shkokani; Dilip Moonka; Atsushi Yoshida
Journal:  Clin Transplant       Date:  2019-10-22       Impact factor: 2.863

3.  Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.

Authors:  Carolin Lackner; Walter Spindelboeck; Johannes Haybaeck; Philipp Douschan; Florian Rainer; Luigi Terracciano; Josef Haas; Andrea Berghold; Ramon Bataller; Rudolf E Stauber
Journal:  J Hepatol       Date:  2016-11-25       Impact factor: 25.083

4.  Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients.

Authors:  Aiman Obed; Steffen Stern; Anwar Jarrad; Thomas Lorf
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

5.  Direct and Indirect Economic Burden of Chronic Liver Disease in the United States.

Authors:  Maria Stepanova; Leyla De Avila; Mariam Afendy; Issah Younossi; Huong Pham; Rebecca Cable; Zobair M Younossi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-07-25       Impact factor: 11.382

Review 6.  Racial disparity in liver disease: Biological, cultural, or socioeconomic factors.

Authors:  Geoffrey C Nguyen; Paul J Thuluvath
Journal:  Hepatology       Date:  2008-03       Impact factor: 17.425

Review 7.  What is the patient experience in advanced liver disease? A scoping review of the literature.

Authors:  Barbara Kimbell; Scott A Murray
Journal:  BMJ Support Palliat Care       Date:  2013-07-02       Impact factor: 3.568

8.  Factors Associated With Access to and Receipt of Liver Transplantation in Veterans With End-stage Liver Disease.

Authors:  Fasiha Kanwal; Ruben Hernaez; Yan Liu; Thomas J Taylor; Abbas Rana; Jennifer R Kramer; Aanand D Naik; Donna Smith; Tamar Taddei; Steven M Asch
Journal:  JAMA Intern Med       Date:  2021-07-01       Impact factor: 44.409

9.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  BMJ       Date:  2018-07-18

10.  The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder.

Authors:  Michael Pimienta; Jennifer Dodge; Norah A Terrault
Journal:  Hepatol Commun       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.